MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
EIKN — Eikon Therapeutics, Inc. Common Stock
NasdaqEikon Therapeutics, Inc. Common Stock
$7.33
-0.08(-1.08%)
- O
- 7.55
- H
- 7.55
- L
- 7.07
- V
- 420.36K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About EIKN
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
SectorNot available
IPO DateFeb 5, 2026
Employees384
Stock ExchangeNasdaq
Ticker SymbolEIKN
Websitehttps://www.eikontx.com
Key Financial Statistics
| Market Cap | $397.03M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $7.07 - $17.40 |
| 52-Week Avg Volume | 446.3K |
| VWAP | $7.27 |
| Transactions | 5,678 |
| Total Recorded Bars | 166 days |